Showing results (2611-2620 of 2,669) with videos related to
Sort By:
Pageof 267
Microbiology Spectrum|December 12, 2024
Advancing poliovirus eradication: lessons learned from piloting direct molecular detection of polioviruses in high-risk and priority geographiesPaula L Marcet, Brandon Short, Ashley Deas, et al.Horticulture Research|September 14, 2020
The Phoebe genome sheds light on the evolution of magnoliidsShi-Pin Chen, Wei-Hong Sun, Yuan-Fang Xiong, et al.Journal of Clinical Microbiology|April 8, 2011
Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populationsVic Veguilla, Kathy Hancock, Jarad Schiffer, et al.Frontiers in Immunology|November 4, 2021
β2-Adrenergic Receptor Enhances the Alternatively Activated Macrophages and Promotes Biliary Injuries Caused by Helminth InfectionStephane Koda, Beibei Zhang, Qian-Yang Zhou, et al.Journal of Medicinal Chemistry|January 26, 2007
Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonistNigel J Liverton, Rodney A Bednar, Bohumil Bednar, et al.The Journal of Clinical Investigation|April 24, 2020
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cellsMin-Hee Oh, Im-Hong Sun, Liang Zhao, et al.BMC Plant Biology|August 13, 2021
OrchidBase 4.0: a database for orchid genomics and molecular biologyYu-Yun Hsiao, Chih-Hsiung Fu, Sau-Yee Ho, et al.Journal of Alzheimer'S Disease : JAD|September 7, 2020
Discovery and Functional Characterization of hPT3, a Humanized Anti-Phospho Tau Selective Monoclonal AntibodyKristof Van Kolen, Thomas J Malia, Clara Theunis, et al.Chinese Medical Journal|November 11, 2021
Prevention and control of HIV/AIDS in China: lessons from the past three decadesJun-Jie Xu, Meng-Jie Han, Yong-Jun Jiang, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|November 27, 2010
[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients]Jinwan Wang, Yan Sun, Yongyu Liu, et al.Pageof 267